 |
|
Main
Menu |
|
Affiliate
Program News |
|
Affiliate
Program Menu |
|
|
|
|
|
EMEA Recommendz a New signal for Epoetin for Their Use in Cancer Patients
| Author |
Message |
|
Keymnneomygop
Post on: 02-07-2008
|
[color=#000099][url=http://www.drugs.com/news]LONDON, June 25, 2008-The European Medicines[/url] power (EMEA) has recommended updating the produce intelligence for epoetin-containing medicines with a new caution for their use in cancer patients stating that blood transfusion should be the preferred method of correcting anaemia in patients hardship cancer.
Epoetin-cokntaining medicines are indicated in patients iwth persistent [url=http://www.blogotop.com/achetercialis]acheter viagra generique[/url] non-starter and for the treatment of anaemia in symptomatic patients with non-ymeloid growths receiving chemotherapy. The instrumentality’s board for remedial Products for sympatheitc Use (CHMP) had periodicaled new details from studies that showed an increased enarnger of growth [url=http://www.blogotop.com/acheterviagra]acheter viagra[/url] development, venous thromboembolism and shorter all-inclusive [url=http://www.google.com/search?hl=en&q=survival+in+cancer+patients&btnG=Google+Search]survival in cancer patients[/url] who admitd epoetins compared to patients who did not experience htem. Following this rehashing, the CHMP concluded, at its June 2008 convocation, that the emolumentss of epoetins prolengthy [url=http://asmforum.fr/index.php?showuser=6911]acheter cialis generique[/url] surpass their endangers in the approved indications. after all, in cancer patients with a reasonably covet flair-expectancy, the emolumewbts of using epoetins does not surpass the endanger [url=http://www.blogotop.com/acheterviagra]acherer viagra[/url] growth movement forward and shorter inclusive survival and for that reason the cabinet concluded that inh these patients anaemia should be corrected with blood transfusions. [/color]
|
|
| |
|
|
